1. UNEXPLAINED VISUAL LOSS AFTER GAS TAMPONADE FOR MACULA-ON RETINAL DETACHMENT: Incidence and Clinical Characterization.
- Author
-
Iuliano L, Corbelli E, Ramoni A, Bandello F, and Codenotti M
- Subjects
- Adult, Blindness diagnosis, Blindness etiology, Female, Follow-Up Studies, Humans, Incidence, Italy epidemiology, Macula Lutea diagnostic imaging, Male, Middle Aged, Retinal Detachment diagnosis, Retrospective Studies, Tomography, Optical Coherence, Blindness epidemiology, Endotamponade adverse effects, Macula Lutea surgery, Retinal Detachment surgery, Silicone Oils adverse effects, Visual Acuity, Vitrectomy adverse effects
- Abstract
Purpose: To identify the incidence rate and the clinical characteristics of unexplained visual loss after gas tamponade for primary macula-sparing rhegmatogenous retinal detachment., Methods: Retrospective longitudinal analysis of all subjects undergoing vitrectomy with gas for primary macula-on rhegmatogenous retinal detachment from 2010 to 2019. Outcome was the unexplained visual loss evaluated after gas absorption, defined as a loss of vision to less than 20/200 without evident causes. The diagnostic workup was reviewed., Results: Nine eyes with unexplained visual loss of 357 surgeries were found. The incidence proportion was 2.52 new cases every 1,000 eyes affected by macula-on rhegmatogenous retinal detachment treated with gas per year. All subjects had an absolute central scotoma, with a median postoperative visual acuity of 20/1,600 (counting fingers). Structural findings were consistent with an axonal damage; all eyes had microcystoid macular edema and reduced thickness of both macular ganglion cell and retinal nerve fiber layers. No photoreceptor structural damages were noted., Conclusion: The incidence of unexplained visual loss after gas tamponade for primary macula-on rhegmatogenous retinal detachment is 2.52 new cases every 1,000 eyes per year. This rare complication, which findings are suggestive of an axonal damage within retinal ganglion cells, remains a serious and unexplained concern for vitreoretinal surgeons.
- Published
- 2021
- Full Text
- View/download PDF